Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.040 EUR
−47.52 M EUR
506.05 M EUR
45.51 M
About Azenta, Inc.
Sector
Industry
CEO
John P. Marotta
Website
Headquarters
Burlington
Founded
1978
Identifiers
3
ISIN US1143401024
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange Azenta, Inc. stocks are traded under the ticker BA3.
We've gathered analysts' opinions on Azenta, Inc. future price: according to them, BA3 price has a max estimate of 42.78 EUR and a min estimate of 26.52 EUR. Watch BA3 chart and read a more detailed Azenta, Inc. stock forecast: see what analysts think of Azenta, Inc. and suggest that you do with its stocks.
Yes, you can track Azenta, Inc. financials in yearly and quarterly reports right on TradingView.
Azenta, Inc. is going to release the next earnings report on Feb 11, 2026. Keep track of upcoming events with our Earnings Calendar.
BA3 earnings for the last quarter are 0.18 EUR per share, whereas the estimation was 0.16 EUR resulting in a 10.81% surprise. The estimated earnings for the next quarter are 0.12 EUR per share. See more details about Azenta, Inc. earnings.
Azenta, Inc. revenue for the last quarter amounts to 135.66 M EUR, despite the estimated figure of 133.12 M EUR. In the next quarter, revenue is expected to reach 125.23 M EUR.
BA3 net income for the last quarter is 43.36 M EUR, while the quarter before that showed −44.83 M EUR of net income which accounts for 196.72% change. Track more Azenta, Inc. financial stats to get the full picture.
As of Jan 9, 2026, the company has 3 K employees. See our rating of the largest employees — is Azenta, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Azenta, Inc. EBITDA is 39.73 M EUR, and current EBITDA margin is 8.41%. See more stats in Azenta, Inc. financial statements.
Like other stocks, BA3 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Azenta, Inc. stock right from TradingView charts — choose your broker and connect to your account.